Centiva Capital LP Invests $355,000 in Astrana Health, Inc. (NASDAQ:ASTH)

Centiva Capital LP acquired a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 11,244 shares of the company’s stock, valued at approximately $355,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brevan Howard Capital Management LP acquired a new stake in Astrana Health in the 4th quarter valued at $495,000. Bank of America Corp DE grew its stake in Astrana Health by 44.2% in the 4th quarter. Bank of America Corp DE now owns 97,721 shares of the company’s stock valued at $3,081,000 after acquiring an additional 29,971 shares during the period. 325 Capital LLC grew its stake in Astrana Health by 30.3% in the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company’s stock valued at $27,964,000 after acquiring an additional 206,009 shares during the period. Northern Trust Corp grew its stake in Astrana Health by 10.1% in the 4th quarter. Northern Trust Corp now owns 467,179 shares of the company’s stock valued at $14,730,000 after acquiring an additional 43,032 shares during the period. Finally, Quarry LP grew its stake in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock valued at $57,000 after acquiring an additional 471 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Trading Down 11.3%

Shares of ASTH stock opened at $29.67 on Monday. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The stock’s fifty day moving average is $30.90 and its two-hundred day moving average is $36.14. The firm has a market capitalization of $1.66 billion, a P/E ratio of 22.82, a PEG ratio of 1.37 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.14). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the previous year, the business posted $0.31 EPS. The company’s revenue was up 53.4% compared to the same quarter last year. Research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on ASTH shares. Truist Financial dropped their price target on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Bank of America dropped their price target on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research note on Tuesday, March 4th. Stifel Nicolaus decreased their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Barclays started coverage on Astrana Health in a report on Tuesday, April 1st. They issued an “equal weight” rating and a $36.00 price objective on the stock. Finally, Robert W. Baird decreased their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.